JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on June 1, 2001
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
276/23/19913    most recent
M100448200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Virts, E. L.
Right arrow Articles by Raschke, W. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Virts, E. L.
Right arrow Articles by Raschke, W. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print March 16, 2001
J. Biol. Chem, 10.1074/jbc.M100448200
Submitted on January 17, 2001
Revised on February 26, 2001
Accepted on March 16, 2001

The role of intron sequences in high level expression from CD45 cDNA constructs

Elizabeth L. Virts and William C. Raschke

Sidney Kimmel Cancer Center, San Diego, CA 92121

Corresponding Author: braschke{at}skcc.org

Consistent expression from CD45 cDNA constructs has proven difficult to achieve. Through the use of new CD45 cDNA constructs and reporter genes, the role 5', 3' and intron sequences play in CD45 expression was determined. The CD45 polyadenylation signal sequence was fully functional in a b-galactosidase reporter construct. Furthermore, the CD45 3' UTR and downstream sequences were shown to contain no negative regulatory elements. Several new CD45 cDNA constructs were designed which contain either the cytomegalovirus (CMV) promoter, the LFA-1 (CD11a) promoter, or various CD45 5' regions. Neither the CMV nor the LFA-1 promoter was capable of generating detectable levels of expression in constructs with CD45 cDNA. However, when CD45 intron sequences between exons 3 and 9 were inserted in the cDNA construct to generate a CD45 minigene, the LFA-1 promoter was able to drive reproducible, significant expression of CD45. CD45 minigenes using the CD45 5' sequences up to 19 kb upstream of the transcriptional start produced very little protein. The LFA-1 CD45 minigene construct produced correct cell type specific isoforms when expressed in T and B lymphocyte lines. Therefore, we conclude that the regulation of CD45 expression and cell type specific splicing requires elements within the intron sequences.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Plant CellHome page
A. B. Rose, T. Elfersi, G. Parra, and I. Korf
Promoter-Proximal Introns in Arabidopsis thaliana Are Enriched in Dispersed Signals that Elevate Gene Expression
PLANT CELL, March 1, 2008; 20(3): 543 - 551.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M.-X. Zhang, H. Ou, Y. H. Shen, J. Wang, J. Wang, J. Coselli, and X. Li Wang
Regulation of endothelial nitric oxide synthase by small RNA
PNAS, November 22, 2005; 102(47): 16967 - 16972.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
L. C. Filip and N. I. Mundy
Rapid Evolution by Positive Darwinian Selection in the Extracellular Domain of the Abundant Lymphocyte Protein CD45 in Primates
Mol. Biol. Evol., August 1, 2004; 21(8): 1504 - 1511.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. L. Virts, O. Diago, and W. C. Raschke
A CD45 minigene restores regulated isoform expression and immune function in CD45-deficient mice: therapeutic implications for human CD45-null severe combined immunodeficiency
Blood, February 1, 2003; 101(3): 849 - 855.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.